Interestingly, double knock down of CXCR4 + CCR5 was more effective in decreasing the migration of hAT-MSCs toward medulloblastoma-BTICs or AT/RT-BTICs (Fig 6B and 6C and S4 Table). The gene discussed is CCR5; the disease is medulloblastoma.